Editorial: Preterm Birth and Infection: Pathogenic Possibilities

American Journal of Reproductive Immunology and Microbiology

Volumn 16, Issue 3, 1988, Pages 123-132

  McGREGOR, JAMES A ^a   FRENCH, JANICE I ^a   LAWELLIN, DAVID ^a,b   TODD, JAMES K ^b  

^a Departments of Obstetrics and Gynecology ^*  (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

infection; inflammation; Prematurity

Indexed keywords

HYALURONIDASE; IMMUNOGLOBULIN A; INTERFERON; LYMPHOKINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROTEINASE; SIALIDASE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

EDITORIAL; HUMAN; INFECTION; INFLAMMATION; MICROORGANISM; PREMATURITY; PRIORITY JOURNAL;

FEMALE; HUMAN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0023934798     PISSN: 87558920     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1988.tb00181.x     Document Type: Article

References (100)

1. Obstetrics in broad perspective
2. Statistics on perinatal morbidity and mortality
3. The contribution of low birth weight to infant mortality and childhood morbidity
4. Contribution to preterm delivery to perinatal mortality
5. Years of Potential Life Lost Attributable to Low Birth‐weight‐United States‐1980 Birth Cohort
6. Committee to Study the Prevention of Low Birthweight
7. Antenatal identification of women at high risk of spontaneous pre‐term birth
8. Can preterm delivery be prevented?
9. Effect of food supplementation during pregnancy on birthweight
10. Single‐centre randomized trial of ritodrine hydrochloride for preterm labour
11. Causes of preterm delivery
12. Vaginal microbial flora: Practical and theoretic relevance
13. The myometrium and uterine cervix in normal and preterm labor
14. Prostaglandins and human parturition: regulation of arachidonic acid mobilization
15. Initiation of parturition in the human female
16. Source of prostaglandin precursor in human fetal membranes: Arachidonic acid content of amnion and chorion leave in diamnionic‐dichorionic twin placentas
17. 2in human fetal membranes
18. Phosphatidylinositol‐specific phospholipase C in fetal membranes and uterine decidua
19. Diacylglycerol metabolism and arachidonic acid release in human fetal membranes and decidua vera
20. Regulation of diacylglycerol metabolism and arachidonic acid release in human amniotic tissue
21. Sweeping the fetal membranes by a physiologic saline solution. Effect on decidual cells
22. Metabolism of platelet activating factor in human fetal membranes and decidua vera
23. Biology and biochemistry of platelet activating factor
24. Platelet‐activating factor: evidence of 1‐0‐alkyl‐2‐acetylsn glyceryl‐3‐phosphoryl‐choline as the active component (a new class of lipid chemical mediators)
25. Platelet activating factor (PAF) involvement in endotoxin‐induced hypotension in rats. Studies with PAF‐receptor antagonist kadsurenone
26. Platelet‐activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet‐activating factor
27. Mass spectrometric evidence for the presence of platelet‐activating factor in human amniotic fluid during labor
28. Identification of phospholipid platelet activating factor in human amniotic fluid and urine
29. The role of platelet‐activating factor in human fetal lung maturation
30. Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether‐linked choline‐phospholipids
31. Purification and characterization of a lysophospholipase from human amnionic membranes
32. 2 are related to substrates of pp60 v‐src and of the epidermal growth factor receptor/kinase
33. Premature rupture of membranes and maternal‐fetal infection
34. Prematurity: Infection as an etiologic factor
35. Epidemiology and aetiology of the preterm baby
36. Premature rupture of membranes and ascending infection
37. Spontaneous early preterm labour associated with abnormal genital bacterial colonization
38. Epidemiology of preterm delivery
39. Relation of poverty and race to antenatal infection
40. Prevalence of six sexually transmitted disease agents among pregnant inner‐city adolescents and pregnancy outcome
41. Asymptomatic gonorrhea and pregnancy
42. Neonatal gonoccal infection. I. Orogastric contamination with Neisseria gonorrhoeae.
43. Premature rupture of membranes, preterm delivery and group B streptococcal colonization of mothers
44. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infection
45. Cervical chlamydia trachomatis and mycoplasmal infections in pregnancy: Epidemiology and outcomes
46. Chlamydia trachomatis infection and pregnancy outcome
47. Low birthweight, prematurity, and postpartum endometritis: Associations with prenatal Mycoplasma hominis and Chlamydia trachomatis infection
48. Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality
49. Low birth weight, prematurity, and postpartum endometritis
50. Bacterial vaginosis during pregnancy, an association with prematurity and postpartum complications
51. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis
52. Independent associations between bacterial vaginosis and chlamydia trachomatis infection and adverse pregnancy outcome
53. Risk factors for prematurity and premature rupture of membranes: A prospective study of vaginal flora in pregnancy. Am J Obstet Gynecol. 1984; 150:965. membranes
54. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women
55. Antibiotic elimination of group B streptococci in prevention of preterm labor
56. The role of infection in premature rupture of membranes
57. Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor
58. Amniocentesis in the evaluation of premature labor
59. Intraamniotic bacterial colonization in premature labor
60. Silent chorioamnionitis as a cause of preterm labor refractory to tocolytic therapy
61. Microbiologic and maturity studies on amniotic fluid as aids in the management of preterm labor
62. Bacterial invasion of amniotic cavity during pregnancy and labor
63. Maternal C‐reactive protein and preterm labor
64. Antibacterial activity of amniotic fluid in the early third trimester: Its association with preterm labor and delivery
65. The natural history of asymptomatic bacteruria during pregnancy: The effect of tetracycline on clinical course and outcome of pregnancy
66. Genital mycoplasmas as a cause of excess premature delivery
67. Effect on birthweight of erythromycin treatment of pregnant women
68. New concepts of destructive periodontal disease
69. Microbial IgA proteases
70. Survey of immunoglobulin A protease activity among selected species of Urea‐plasmas and Mycoplasmas: Specificity for host immunoglobulin A
71. Premature labor II. Bacterial sources of phospholipase
72. Effect of bacterial production prostaglandin E production by amnion cells
73. Release of decay‐accelerating factor (DAF) from the cell membrane by phosphatidylinositol‐specific phospholipase C (P1PLC): Selective modification of a complement regulatory protein
74. Microorganisms and arachidonic acid metabolites in preterm birth
75. An update of human interleukin‐1 from molecular biology to clinical relevance
76. Low‐moiecular‐weight immunomodifiers produced by microorganisms
77. Oxygen radicals dipolymerize purified hyaluvanic acid
78. Lipid peroxidation in maternal and cord blood and protective mechanisms against activated‐oxygen toxicity in blood
79. Interactions between membrane and cytolytic bacterial toxins
80. Protease production by microorganisms associated with reproductive tract infection
81. In vitro study of bacterial protease‐induced reduction of chorioamniotic membrane strength and elasticity
82. Effect of bacterial growth on the bursting pressure of fetal membranes in vitro
83. Infection and phagocytosis as possible mechanism of rupture in premature rupture of the membranes
84. High levels of serum collagenase in preterm labor—a potential biochemical marker
85. Adjunctive erythromycin treatment for idiopathic preterm labor: Results of a randomized, double‐blinded, placebo‐controlled trial